308 related articles for article (PubMed ID: 20434957)
21. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
[TBL] [Abstract][Full Text] [Related]
22. Herpes zoster and postherpetic neuralgia in older adults.
Schmader K
Clin Geriatr Med; 2007 Aug; 23(3):615-32, vii-viii. PubMed ID: 17631237
[TBL] [Abstract][Full Text] [Related]
23. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study.
Drolet M; Levin MJ; Schmader KE; Johnson R; Oxman MN; Patrick D; Fournier SO; Mansi JA; Brisson M
Vaccine; 2012 Mar; 30(12):2047-50. PubMed ID: 22285632
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.
Dworkin RH; Gnann JW; Oaklander AL; Raja SN; Schmader KE; Whitley RJ
J Pain; 2008 Jan; 9(1 Suppl 1):S37-44. PubMed ID: 18166464
[TBL] [Abstract][Full Text] [Related]
25. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data.
Klompas M; Kulldorff M; Vilk Y; Bialek SR; Harpaz R
Mayo Clin Proc; 2011 Dec; 86(12):1146-53. PubMed ID: 21997577
[TBL] [Abstract][Full Text] [Related]
26. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
[TBL] [Abstract][Full Text] [Related]
27. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
28. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.
Takao Y; Miyazaki Y; Okeda M; Onishi F; Yano S; Gomi Y; Ishikawa T; Okuno Y; Mori Y; Asada H; Yamanishi K; Iso H
J Epidemiol; 2015; 25(10):617-25. PubMed ID: 26399445
[TBL] [Abstract][Full Text] [Related]
29. Correlation Between Electromyography and Severity and Prognosis of Upper Limb Herpes Zoster.
Tang J; Luo G; Tao J; Zhu J; He Q; Ni H; Xie K; Xu L; Yao M
Pain Physician; 2022 Aug; 25(5):E749-E757. PubMed ID: 35901486
[TBL] [Abstract][Full Text] [Related]
30. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
31. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
Johnson RW; Bouhassira D; Kassianos G; Leplège A; Schmader KE; Weinke T
BMC Med; 2010 Jun; 8():37. PubMed ID: 20565946
[TBL] [Abstract][Full Text] [Related]
32. Management of herpes zoster (shingles) and postherpetic neuralgia.
Johnson RW; Whitton TL
Expert Opin Pharmacother; 2004 Mar; 5(3):551-9. PubMed ID: 15013924
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for postherpetic neuralgia in patients with herpes zoster.
Jung BF; Johnson RW; Griffin DR; Dworkin RH
Neurology; 2004 May; 62(9):1545-51. PubMed ID: 15136679
[TBL] [Abstract][Full Text] [Related]
34. Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study.
Díez-Domingo J; Curran D; Cambronero MDR; Garcia-Martinez JA; Matthews S
Adv Ther; 2021 Jun; 38(6):3325-3341. PubMed ID: 34013498
[TBL] [Abstract][Full Text] [Related]
35. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine.
Schmader K; Gnann JW; Watson CP
J Infect Dis; 2008 Mar; 197 Suppl 2():S207-15. PubMed ID: 18419399
[TBL] [Abstract][Full Text] [Related]
36. Postherpetic neuralgia: epidemiology, pathophysiology and management.
Johnson RW; Wasner G; Saddier P; Baron R
Expert Rev Neurother; 2007 Nov; 7(11):1581-95. PubMed ID: 17997705
[TBL] [Abstract][Full Text] [Related]
37. Complex regional pain syndrome-like symptoms during herpes zoster.
Berry JD; Rowbotham MC; Petersen KL
Pain; 2004 Jul; 110(1-2):e1-12. PubMed ID: 15275746
[TBL] [Abstract][Full Text] [Related]
38. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
39. Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study.
Bricout H; Perinetti E; Marchettini P; Ragni P; Zotti CM; Gabutti G; Volpi A; Franco E
BMC Infect Dis; 2014 Dec; 14():637. PubMed ID: 25479617
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.
Cebrián-Cuenca AM; Díez-Domingo J; San-Martín-Rodríguez M; Puig-Barberá J; Navarro-Pérez J;
BMC Infect Dis; 2011 Nov; 11():302. PubMed ID: 22044665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
